Analgesic Treatment Articles & Analysis
2 news found
Cebranopadol is the first and only dual nociceptin/orphanin FQ peptide (NOP) receptor and ยต-opioid peptide (MOP) receptor agonist (dual-NMR) analgesic in clinical development for the treatment of moderate to severe pain, as well as opioid use disorder (OUD). ...
Dworkin is the Director of the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership with the U.S. ...